Thomas R. Cannell
2019 - Eleven Biotherapeutics
In 2019, Thomas R. Cannell earned a total compensation of $1.4M as President and Chief Executive Officer at Eleven Biotherapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $312,000 |
|---|---|
| Option Awards | $568,244 |
| Salary | $520,000 |
| Other | $4,000 |
| Total | $1,404,244 |
Cannell received $568.2K in option awards, accounting for 40% of the total pay in 2019.
Cannell also received $312K in non-equity incentive plan, $520K in salary and $4K in other compensation.
Rankings
In 2019, Thomas R. Cannell's compensation ranked 7,650th out of 13,971 executives tracked by ExecPay. In other words, Cannell earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,650 out of 13,971 | 45th |
Division Manufacturing | 2,982 out of 5,701 | 48th |
Major group Chemicals And Allied Products | 1,121 out of 2,200 | 49th |
Industry group Drugs | 955 out of 1,886 | 49th |
Industry Pharmaceutical Preparations | 709 out of 1,398 | 49th |
Source: SEC filing on March 30, 2020.
Cannell's colleagues
We found three more compensation records of executives who worked with Thomas R. Cannell at Eleven Biotherapeutics in 2019.
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019